Tech Company Financing Transactions
miDiagnostics Funding Round
Thermo Fisher Scientific, Alychlo NV and Pamica participated in a $31.7 million Series D funding round for miDiagnostics. The round was announced on 12/4/2024.
Transaction Overview
Company Name
Announced On
12/4/2024
Transaction Type
Venture Equity
Amount
$31,700,000
Round
Series D
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the development of a sterility test for batch release and related quality control tests for the BioPharma Industry, utilizing its proprietary qPCR technology.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Gaston Geenslaan 1
Heverlee, 3001
Belgium
Heverlee, 3001
Belgium
Phone
Website
Email Address
Overview
The company is spun out of imec, the world-leading R&D and innovation hub in nanoelectronics and digital technologies, and a research collaboration with Johns Hopkins University, the leading US research and medical center. Our proprietary silicon chip and reader require only a small sample volume. The sample moves through the PCR card using capillary forces alone.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Katleen Verleysen
Chief Financial Officer
Frank Hazevoets
Chief Operating Officer
Ben Chambers
VP - Manufacturing
Olivier Desmarets
VP - Product Management
Tom Willshare
VP - R & D
Mireille Maenhoudt
VP - Regulatory Affairs
Vesna Kostanjevecki
Browse more venture capital transactions:
Prev: 12/4/2024: Khloud venture capital transaction
Next: 12/4/2024: System Two Security venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. All VC database entries reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs